Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析

◆英語タイトル:Catabasis Pharmaceuticals Inc (CATB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15038
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and rationally targeted (SMART) Linker drug discovery platform for rare diseases, among others. Its product candidate edasalonexent CAT-1004, currently under Phase 3 trial, is an oral small molecule intended for the treatment of Duchenne muscular dystrophy. CAT-5571, an activator of autophagy and the company’s lead product under preclinical stage, is an oral small molecule for the treatment of cystic fibrosis. The company’s CAT-4001 is used for the treatment of neurodegenerative diseases such as Friedreich’s ataxia and amyotrophic lateral sclerosis (ALS). Catabasis Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Catabasis Pharmaceuticals Inc Key Recent Developments

Feb 14,2019: Catabasis Pharmaceuticals appoints Joanne T. Beck to its board of directors
Jan 04,2019: Catabasis Pharmaceuticals names Gregg Lapointe as board director
Nov 27,2018: Catabasis Pharmaceuticals Announces Publication of Phase 1 Clinical Results of Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy
Nov 13,2018: Catabasis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Reviews Business Progress
Oct 03,2018: Catabasis Pharmaceuticals Presents Data Supporting MRI T2 as a Potential Marker of Clinical Outcome in Duchenne Muscular Dystrophy at the World Muscle Society Congress

This comprehensive SWOT profile of Catabasis Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Catabasis Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Catabasis Pharmaceuticals Inc – Key Information
Catabasis Pharmaceuticals Inc – Overview
Catabasis Pharmaceuticals Inc – Key Employees
Catabasis Pharmaceuticals Inc – Key Employee Biographies
Catabasis Pharmaceuticals Inc – Key Operational Heads
Catabasis Pharmaceuticals Inc – Major Products and Services
Catabasis Pharmaceuticals Inc – History
Catabasis Pharmaceuticals Inc – Company Statement
Catabasis Pharmaceuticals Inc – Locations And Subsidiaries
Catabasis Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Catabasis Pharmaceuticals Inc – Business Description
Catabasis Pharmaceuticals Inc – Corporate Strategy
Catabasis Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Catabasis Pharmaceuticals Inc – Strengths
Catabasis Pharmaceuticals Inc – Weaknesses
Catabasis Pharmaceuticals Inc – Opportunities
Catabasis Pharmaceuticals Inc – Threats
Catabasis Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Catabasis Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Catabasis Pharmaceuticals Inc, Key Information
Catabasis Pharmaceuticals Inc, Key Ratios
Catabasis Pharmaceuticals Inc, Share Data
Catabasis Pharmaceuticals Inc, Major Products and Services
Catabasis Pharmaceuticals Inc, History
Catabasis Pharmaceuticals Inc, Key Employees
Catabasis Pharmaceuticals Inc, Key Employee Biographies
Catabasis Pharmaceuticals Inc, Key Operational Heads
Catabasis Pharmaceuticals Inc, Other Locations
Catabasis Pharmaceuticals Inc, Subsidiaries
Catabasis Pharmaceuticals Inc, Key Manufacturing facilities
Catabasis Pharmaceuticals Inc, Key Competitors
Catabasis Pharmaceuticals Inc, SWOT Analysis
Catabasis Pharmaceuticals Inc, Ratios based on current share price
Catabasis Pharmaceuticals Inc, Annual Ratios
Catabasis Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Catabasis Pharmaceuticals Inc, Performance Chart
Catabasis Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Integer Holdings Corp (ITGR):医療機器:M&Aディール及び事業提携情報
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • Newpark Resources Inc (NR):企業の財務・戦略的SWOT分析
    Newpark Resources Inc (NR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Windtree Therapeutics Inc (WINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • G3 Exploration Ltd (GDG):石油・ガス:M&Aディール及び事業提携情報
    Summary G3 Exploration Ltd (G3 Exploration), formerly Green Dragon Gas Ltd, is an oil and gas company that offers exploration and production of coal bed methane gas. The company offers services such as exploration, transportation fleet operations, retail CNG stations, and production programs, among …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Kimball Electronics, Inc. (KE):企業の財務・戦略的SWOT分析
    Kimball Electronics, Inc. (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nagacorp Ltd:戦略・SWOT・企業財務分析
    Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report Summary Nagacorp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Koppers Holdings Inc (KOP):企業の財務・戦略的SWOT分析
    Koppers Holdings Inc (KOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Nichiha Corporation:企業の戦略・SWOT・財務情報
    Nichiha Corporation - Strategy, SWOT and Corporate Finance Report Summary Nichiha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Korber AG:企業の戦略・SWOT・財務情報
    Korber AG - Strategy, SWOT and Corporate Finance Report Summary Korber AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Franklin Resources, Inc.:企業の戦略・SWOT・財務情報
    Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tamedia AG:企業のM&A・事業提携・投資動向
    Tamedia AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tamedia AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Aiphone Co Ltd (6718):企業の財務・戦略的SWOT分析
    Aiphone Co Ltd (6718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank of China Ltd:企業のM&A・事業提携・投資動向
    Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Brake Bros Ltd:企業の戦略的SWOT分析
    Brake Bros Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Anchor Glass Container Corp.:企業の戦略・SWOT・財務情報
    Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report Summary Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design …
  • Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Pharmerica Corp:企業の戦略的SWOT分析
    Pharmerica Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sika Interplant Systems Limited:企業の戦略・SWOT・財務分析
    Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report Summary Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆